Lets stop looking in the rear vision mirror hey? Im as impatient as the next guy, but keep focus on what RAC has here that other companies don't.
Your invested in the drug, thats all BP care about. And its still very much in the RACe.
Prior announcements have stated Bisantrene "May" have utility across 15% of all cancers, due to FTO over expression being present in that population.
This announcement Specifically shows it at low concentrations, thats the difference.
Before the language was it "may" or it "potentially" works across many, now we know it does. Wake up people.
Ann: Bisantrene Shows Broad Anti-Cancer Activity in Cancer Cells, page-35
-
- There are more pages in this discussion • 184 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.47 |
Change
-0.005(0.34%) |
Mkt cap ! $249.7M | |||
| Open | High | Low | Value | Volume |
| $1.48 | $1.50 | $1.46 | $129.2K | 87.73K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7418 | $1.47 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.49 | 38353 | 1 |
View Market Depth
| Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |